John Moriarty
Director/Board Member chez American Kidney Fund, Inc.
Profil
John B.
Moriarty is currently the Secretary & Trustee at American Kidney Fund, Inc. He previously worked as the Executive Director & Senior Counsel at Amgen, Inc. from 2002 to 2008.
From 2008 to 2012, he served as the Chief Legal Officer & General Counsel at Elan Corp.
Plc.
He then worked as the Executive Vice President & General Counsel at Alexion Pharmaceuticals, Inc. from 2012 to 2018.
From 2018 to 2020, he held the position of Secretary, Executive VP & General Counsel at Portola Pharmaceuticals LLC.
Currently, he is also the Secretary & Chief Legal Officer at Mirati Therapeutics, Inc. Since 2020, he has been serving as the Secretary, Chief Legal Officer & Executive VP at Olema Pharmaceuticals, Inc. Mr. Moriarty completed his undergraduate studies at the University of Virginia and obtained his graduate degree from the University of Georgia School of Law.
Postes actifs de John Moriarty
| Sociétés | Poste | Début |
|---|---|---|
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Director/Board Member | 01/01/2015 |
Anciens postes connus de John Moriarty
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | General Counsel | 23/01/2024 |
| OLEMA PHARMACEUTICALS, INC. | General Counsel | 01/05/2023 |
| PORTOLA PHARMACEUTICALS, INC. | General Counsel | 01/07/2020 |
| ALEXION PHARMACEUTICALS, INC. | General Counsel | 01/02/2018 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | General Counsel | 01/12/2012 |
Formation de John Moriarty
| University of Virginia | Undergraduate Degree |
| University of Georgia School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Health Services |
